ExodusPoint Capital Management’s Fulgent Genetics FLGT Stock Holding History

ExodusPoint Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$966K	Buy	+47,087	New	+$798K	0.01%	1087
2026 Q1	–	Sell	-13,975	Closed	-$367K	–	1728
2025 Q4	$367K	Buy	+13,975	New	+$363K	﹤0.01%	1260
2025 Q3	–	Sell	-38,494	Closed	-$765K	–	1694
2025 Q2	$765K	Buy	+38,494	New	+$750K	0.01%	1040
2025 Q1	–	Sell	-92,197	Closed	-$1.7M	–	1641
2024 Q4	$1.7M	Buy	92,197 +39,618	+75%	+$773K	0.01%	772
2024 Q3	$1.14M	Sell	52,579 -40,202	-43%	-$899K	0.01%	932
2024 Q2	$1.82M	Buy	+92,781	New	+$1.94M	0.01%	817
2024 Q1	–	Sell	-20,079	Closed	-$580K	–	1639
2023 Q4	$580K	Sell	20,079 -2,025	-9%	-$54.2K	﹤0.01%	992
2023 Q3	$591K	Buy	22,104 +135	+0.6%	+$4.61K	0.01%	1177
2023 Q2	$814K	Sell	21,969 -61,858	-74%	-$2.16M	0.01%	1182
2023 Q1	$2.62M	Buy	+83,827	New	+$2.7M	0.02%	774
2022 Q4	–	Sell	-13,303	Closed	-$507K	–	1781
2022 Q3	$507K	Sell	13,303 -10,402	-44%	-$521K	0.01%	1369
2022 Q2	$1.29M	Buy	23,705 +16,333	+222%	+$898K	0.02%	961
2022 Q1	$460K	Buy	7,372 +4,086	+124%	+$269K	0.01%	1580
2021 Q4	$331K	Buy	+3,286	New	+$289K	﹤0.01%	1618
2020 Q2	–	Sell	-33,728	Closed	-$363K	–	1850
2020 Q1	$363K	Sell	33,728 -107	-0.3%	-$1.49K	0.02%	593
2019 Q4	$436K	Buy	+33,835	New	+$402K	0.01%	941

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ExodusPoint Capital Management's FLGT Position: Q2 2026 in Review

ExodusPoint Capital Management opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 47,087 shares worth $966K. The stake represents 0.01% of the portfolio and ranks #1087 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in FLGT as recently as Q4 2025.

ExodusPoint Capital Management first reported a position in FLGT in Q4 2019 and has held it in 16 quarters since. The position peaked at $2.62M in Q1 2023. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

ExodusPoint Capital Management held 47,087 shares of Fulgent Genetics worth $966K as of Q2 2026.
Fulgent Genetics was a new ExodusPoint Capital Management position in Q2 2026.
Fulgent Genetics made up 0.01% of ExodusPoint Capital Management's portfolio in Q2 2026, its #1087 holding.
ExodusPoint Capital Management first reported a position in Fulgent Genetics in Q4 2019 and has held it in 16 quarters since.
ExodusPoint Capital Management's Fulgent Genetics position peaked at $2.62M in Q1 2023.
142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.